⌕
LifeStance Health Group · LFST · Nasdaq
Tenet 54 · Mixed
Compare
$14.48+2.84%At closeTenet 54 · Mixed
$14.48+0.40 (+2.84%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

LifeStance Health Group (LFST) Earnings Forecast

Analysts expect LifeStance Health Group (LFST) to earn $0.20 a share in FY26, the average of 4 estimates as of Nov 13, 2026.

Sources Analyst estimates EstimatesConsensus as of How we compute thisNot investment advice

10 figures withheld by our checks. Each blank figure names its reason.

FY26 consensus EPS
$0.20
4 analysts
FY27 consensus EPS
$0.24
5 analysts · low $0.23, high $0.25
EPS revisions, 30 days
+23.8%
$0.16 to $0.20
Disagreement, FY26
16.7%
high to low, $0.19 to $0.22

Consensus estimates only. Analysts' price forecasts and ratings are not licensed here.

Consensus as of Nov 13, 2026 · we check it nightly

Analysts expect LifeStance Health Group to earn $0.45 a share in FY28, growing about 51% a year; 7 analysts publish an estimate for FY28.

Forward P/E · FY26E
70.8×
$14.08 (as of close, Nov 13, 2026) ÷ $0.20 consensus EPS
Coverage · FY26
4 · 8
EPS estimates · revenue estimates

Are estimates going up or down lately?

The FY26 EPS consensus is $0.20, up 44.3% in 91 days. Every figure compares one fiscal period at both ends.

EPS consensus, change over the last 91 days. One step per nightly change.

−8.0%+22.1%+52.3%FY26 +44.3%FY27 +20.5%Aug 15Nov 13
EPS30 days90 daysshown aboveSince Jul 6
FY264 analysts▲ +23.8%$0.16 to $0.20▲ +44.3%$0.14 to $0.20▲ +46.0%$0.14 to $0.20
FY275 analysts▲ +11.5%$0.22 to $0.24▲ +20.5%$0.20 to $0.24▲ +22.6%$0.20 to $0.24
Sep '264 analysts◆ 0.0%$0.04 to $0.04▲ +0.7%$0.04 to $0.04▲ +0.7%$0.04 to $0.04
Dec '263 analysts▲ +20.9%$0.04 to $0.05▲ +21.2%$0.04 to $0.05▲ +21.2%$0.04 to $0.05

Contributors at both ends of the window: FY26 5 and 4. A change in the average can come from a new contributor as much as from a changed mind, so both counts stay in view.

Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.

If the Street is right, what does that imply for the share price?

Price as of close, Nov 13, 2026 · consensus as of Nov 13, 2026

Pick a fiscal year and a multiple and the sum runs on the numbers the Street published.

Consensus EPS · FY27
$0.24
5 analysts · low $0.23, high $0.25 · thin coverage
Multiple · yours
We hold no multiple of our own for this company, neither today's nor a fiscal-year record, so the multiple can only be yours.
Receipt · LFST · FY27Nov 13, 2026
Implied, a share
Waiting

This is multiplication, not a forecast. It assumes the market pays the multiple you chose and that the consensus is right. Both are often wrong.

You are paying 70.8 times the FY26 consensus for earnings the Street expects to grow about 51% a year to FY28. That is 1.4 times the growth rate.

How much do analysts disagree?

For FY28, estimates run from $0.40 to $0.50 around an average of $0.45, drawn by 7 analysts.

FY26E4 analysts
$0.19 to $0.22 · 16.7%
FY27E5 analysts
$0.23 to $0.25 · 11.5%
FY28E7 analysts
$0.40 to $0.50 · 22.2%

A wide spread is disagreement, not risk; a narrow one is agreement, not accuracy. Later years are always wider because fewer people forecast them. Bars in amber rest on fewer than 15 analysts. The tick on each bar is the average.

Is next quarter a high bar or an easy one?

Analysts expect LifeStance Health Group to earn $0.05 a share in the December quarter, the average of 3 estimates. We hold no expected date for the next report.

Expected report
Not held
No expected date is published for this company's next report, so none is printed here.
Revenue expected · December quarter
$454.7M
5 analysts, 454.6 to 454.7 in $M · 382.2 in the same quarter a year ago

For the March quarter, analysts expect $0.07 a share.

Does LifeStance Health Group usually beat or miss?

We have not been able to check a quarter yet. Our record of estimates for LifeStance Health Group begins on Jul 6, 2026, and a quarter can be checked only when we hold an estimate for it from before the company reported.

We started recording estimates on Jul 6, 2026, so quarters that reported before that date cannot be checked.

Before our record
Dec '23
Our record, one quarter per report
Mar '24left out
Jun '24left out
Sep '24left out
Dec '24left out
Mar '25left out
Jun '25left out
Sep '25left out
Dec '25left out
Mar '26left out
Jun '26left out
Sep '26left out
Dec '26not reported yet
Checked so far
None yet
one more every report
Beat expectations
Nothing to count
the first check lands after the next report
Share price reaction
Not held
there is no checked quarter to measure a reaction for
Typical gap vs estimate
Not yet
shown once 4 quarters are checked

Checked against the company's reported figure (GAAP) and the average estimate we recorded the night before its results release. Where analysts' number is on an adjusted basis, we leave the comparison out rather than force it. We started recording estimates for LifeStance Health Group on Jul 6, 2026, so earlier quarters cannot be checked, and we never fill them in after the fact.

The Street expects sales to grow 13.6% in FY27 and EPS 23.1%. Sales are part of it: the net margin moves from 4.6% to 4.7%, and the implied share count from about 402M to 384M, so these numbers assume the count keeps falling.Show the decomposition and the margin ladderHide the decomposition
FY27 EPS growth, in points
Revenue growth+13.6
Net margin change+3.9
Share count change+5.6
EPS growth+23.1
Legs are rounded to a tenth of a point and the largest remainder carries the difference, so they add to the total. Implied shares = consensus net income ÷ consensus EPS, a direction rather than a decimal.
4 analysts publish an EPS estimate for FY26 and 8 publish revenue. Consensus figures are on the Street's basis and filed figures are GAAP; we label the gap, we do not explain it away.Show coverage by year and over timeHide the coverage chart
Analysts by fiscal year · outlined revenue, filled EPS. Amber marks a panel of fewer than 15.
84
FY26E
85
FY27E
97
FY28E
The FY26 panel held 5 analysts when our record of it began on Jul 6, 2026 and holds 4 tonight.

The full consensus, year by year

Consensus as of Nov 13, 2026 · filed figures as reported
Revenue · $Bfiled · consensus average · band = low to high
0.81.62.4historyStreet forecastFY22FY25FY28E

Coverage thins with distance: 8 revenue estimates for FY26, 9 for FY28.

Diluted EPS · $filed · consensus average · band = low to high
Not enough estimate history to chart yet.

Out-year bands widen as fewer analysts publish: 4 EPS estimates for FY26, 7 for FY28.

Fiscal yearRevenue $BYoYEPS $YoYEBITDA $BNet inc. $BShares BAnalysts rev · EPSFwd P/E
FY25Filed1.4——————as filed76.6×
FY26E1.71.7 to 1.8▲22.7%a0.200.19 to 0.22n/ca0.20.10.408 · 470.8×
FY27E2.02.0 to 2.0▲13.6%0.240.23 to 0.25▲23.1%0.20.10.388 · 557.5×
FY28E2.32.2 to 2.3▲15.1%0.450.40 to 0.50▲85.0%0.30.20.399 · 731.1×

Average estimate with low to high beneath. Amber counts mark thin coverage and thin rows carry an amber rule. Shares = consensus net income ÷ consensus EPS, a direction rather than a decimal. The filed row's last column is today's price over the last four reported quarters, the one trailing multiple in that column. a This step crosses the seam: last year is a filed GAAP actual and this year is a consensus estimate, so the two are not prepared on one basis. b More than a third of the analyst panel changed between these two years, so the difference of the two averages measures the panel rather than the forecast.

These are consensus estimates: what analysts expect the business to earn, not where they think the stock trades. Coverage thins and the low to high band widens in the out-years. Context, not advice.

Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: 4 EPS estimates for FY26, 8 for revenue. Not investment advice.

What do analysts expect LifeStance Health Group to earn in FY26?

Analysts expect LifeStance Health Group to earn $0.20 a share in FY26, the average of 4 estimates as of Nov 13, 2026.

What is LifeStance Health Group's earnings forecast for FY27?

The FY27 consensus for LifeStance Health Group is $0.24 a share from 5 analysts, with a low of $0.23 and a high of $0.25, as of Nov 13, 2026.

Have analysts raised LifeStance Health Group's earnings estimates?

LifeStance Health Group's FY26 EPS consensus rose 44.3% in 91 days, from $0.14 to $0.20, as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.